PPT-VICTR Funding Overview Vanderbilt Institute for Clinical and Translational Research (VICTR)

June 22 2012 Support novel pilot studies that could lead to publications and extramural grants Support studies that impact clinical care and research methodologies Support students and trainees. Consistent with OSHA requirements persons with beards or long sideburns cannot be fit tested due to the inability to get a good facial seal OSHA law prohibits those individuals from wearing a tight fitting respirator until the person is clean shaven By Charles, Cecilia, and Daniel. Cornelius Vanderbilt was a self-made multi-millionaire who acquired his wealth in shipping and the railroad and one of the wealthiest Americans of the 19th century. Vanderbilt went into business for himself in the late 1820s, and eventually became one of the country's largest steamship operators. In the 1860s, he built another empire in the railroad industry. When Vanderbilt died, he was worth more than $100 million.. The Ultimate “Captain of Industry”. Tiara, Isabelle, . Eamonn. , . Yasmine. , Diana. How He Acquired His Wealth. Initiated his empire through railroad transportation. Begun a steamship service that transported prospectors from New York to San Francisco in relation to the Gold Rush in California. David Crabb, M.D.. Director, Indiana Alcohol Research Center. The Handoff. The Circle City . The Crescent City. Questions/Goals. What is interdisciplinary research?. What is translational research?. (VICTR). VICTR Resources – . What’s New/What’s Next!. Tara . Helmer, PA-C, . MPH. Research Services . Consultant. Objectives. Vanderbilt Institute for Clinical and Translational Research . (VICTR). 65. th. Annual . Bohan. Lecture. Scott J. Weir, . PharmD. , PhD. 08 October 2011. Drug Focused Translational Research. Translational Research Defined by the Clinical Problem. Breast Cancer. Clinical Problem. EPID 691, Spring 2012. Epidemiology of Chronic Disease. Nancy L. McCain, RN, DSN, FAAN. NIH Roadmap. http://commonfund.nih.gov/aboutroadmap.aspx. The NIH Roadmap for Medical Research was launched in September, 2004, to address roadblocks to research and to transform the way biomedical research is conducted by . . SYFTET. Göteborgs universitet ska skapa en modern, lättanvänd och . effektiv webbmiljö med fokus på användarnas förväntningar.. 1. ETT UNIVERSITET – EN GEMENSAM WEBB. Innehåll som är intressant för de prioriterade målgrupperna samlas på ett ställe till exempel:. About the Seminar Series. Seminars in Translational Research (STRECH) is a collaborative project between the UTHSCSA Institute for Integration of Medicine and Science / Novel Clinical and Translational Methodologies and the UTSA Department of Biomedical Engineering and Research Centers in Minority Institutions program.. June 22. , 2012. Support novel . pilot. studies that could lead to publications and extramural grants. Support studies that impact clinical care and research methodologies. Support students and trainees. 1. Welcome and Greetings 2. EMBC 18: Theme CoChair nominations: Theme: Translational Engineering for Healthcare Innovation & Commercialization $1,500 honorarium. 4. JTEHM update and Special Issues The UF-FSU hub is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida Clinical and Translational Science Awards UL1TR001427, KL2TR001429 and TL1TR001428.. Clinical and Translational PharmacologyPaul Calabresi Medical StudentResearch Fellowships Clinical and Translational PharmacologyThe Paul Calabresi Fellowship allowed me to venture down new paths dur Presenter: Andrew Speaker MD, Assistant Professor of Pediatrics, _______ University School of Medicine. It is the policy of the ACCME and Vanderbilt University Medical Center to require disclosure of financial relationships from individuals in a position to control the content of a CME activity; to identify and resolve conflicts of interest related to those relationships; and to make disclosure information available to the audience prior to the CME activity.  Presenters are required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. .